(Q79474065)

English

Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US

scientific article published on 01 January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

type 2 diabetes

1 reference

based on heuristic

inferred from title

insulin therapy

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

United States of America

1 reference

based on heuristic

inferred from title

author name string

Ray JA

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Valentine WJ

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Roze S

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Nicklasson L

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Cobden D

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Raskin P

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Garber A

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Palmer AJ

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

103-113

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metformin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: a double-blind crossover study in adults with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Validation of the CORE Diabetes Model against epidemiological and clinical studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Lipid levels and the use of lipid-lowering agents in England and Scotland

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Coverage in screening for diabetic retinopathy according to screening provision: results from a national survey in England and Wales

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Long-term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Spotlight on insulin aspart in type 1 and 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Combined therapy with insulin lispro Mix 75/25 plus metformin or insulin glargine plus metformin: a 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Insulin initiation in Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Treatment options for diabetic neuropathic foot ulcers: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2006.00581.X

21 January 2018

Identifiers

10.1111/J.1463-1326.2006.00581.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17199725%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79474065&oldid=1873243816"